BAKER CHARLES A 4
4 · REGENERON PHARMACEUTICALS INC · Filed Oct 3, 2017
Insider Transaction Report
Form 4
BAKER CHARLES A
Director
Transactions
- Exercise/Conversion
Common Stock
2017-09-29$18.61/sh+2,000$37,220→ 11,000 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-09-29−2,000→ 0 totalExercise: $18.61Exp: 2019-01-02→ Common Stock (2,000 underlying) - Sale
Common Stock
2017-09-29$450.00/sh−2,000$900,000→ 9,000 total
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.